CheckMate 214 Exploratory Biomarker Analysis: Predicting Response to Nivolumab Plus Ipilimumab in Advanced RCC

May 29-31, 2020; Online at meetings.asco.org/am
Biomarker evaluation suggests that prolonged PFS with nivo plus ipi may be associated with enhanced expression of genes involved in the tumor microenvironment and inflammatory responses; PD-L1 expression is not predictive for OS or PFS.
Format: Microsoft PowerPoint (.ppt)
File Size: 278 KB
Released: June 3, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
Bristol-Myers Squibb
Exelixis
Pfizer, Inc. and EMD Serono

Related Content

Clinical Care Options (CCO): Expert analysis from Drs. Daniel Petrylak and Toni Choueiri on key data in genitourinary cancers from ASCO GU 2022

Toni K. Choueiri, MD Daniel P. Petrylak, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: April 18, 2022 Expired: April 17, 2023

Commentary with expert answers to healthcare professional questions on adjuvant therapy for renal cell carcinoma, from Clinical Care Options (CCO)

Brian A. Costello, MD, MS Eric Jonasch, MD Elizabeth R. Plimack, MD, MS Released: April 13, 2022

Commentary with expert answers to healthcare professional questions on therapy for metastatic renal cell carcinoma, from Clinical Care Options (CCO)

Brian A. Costello, MD, MS Eric Jonasch, MD Elizabeth R. Plimack, MD, MS Released: April 13, 2022

Downloadable slideset from Dr. Brian Costello on adjuvant approaches and first line treatment options for patients with RCC, from Clinical Care Options (CCO).

Brian A. Costello, MD, MS Released: March 1, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings